Aortic Intima-Media Thickness as an Early Marker of Atherosclerosis in Children with Inflammatory Bowel Disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 61, Issue 1, 2015, Pages 41-46

  Aloi, Marina ^a   Tromba, Luciana ^b   Rizzo, Valentina ^a   D'Arcangelo, Giulia ^a   Dilillo, Anna ^a   Blasi, Sara ^b   Civitelli, Fortunata ^a   Kiltzanidi, Dimitra ^b   Redler, Adriano ^b   Viola, Franca ^a  

^a POLICLINICO UMBERTO I   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

atherosclerosis; children; endothelial dysfunction; inflammatory bowel disease

Indexed keywords

ADOLESCENT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE MARKER; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FAMILY HISTORY; FEMALE; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; MALE; MULTIVARIATE ANALYSIS; PASSIVE SMOKING; PRIORITY JOURNAL; SEX; ULCERATIVE COLITIS; UNIVARIATE ANALYSIS; AORTA; COMPLICATION; PATHOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM;

NICOTIANA TABACUM;

BIOLOGICAL MARKER;

ADOLESCENT; AORTA; ATHEROSCLEROSIS; BIOMARKERS; BLOOD PRESSURE; CAROTID INTIMA-MEDIA THICKNESS; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; MALE; RISK FACTORS;

EID: 84937696792     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000771     Document Type: Article

References (52)

1. Fiocchi C. Inflammatory bowel disease: evolutionary concepts in biology, epidemiology, mechanisms and therapy. Curr Opin Gastro-enterol 2013;29:347-9.
2. Cader MZ, Kaser A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 2013;62:1653-64.
3. Deban L, Correale C, Vetrano S, et al. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol 2008;172:1457-66.
4. Cromer WE, Mathis JM, Granger DN, et al. Role of endothelium in inflammatory bowel diseases. World J Gastroenterol 2011;17:578-93.
5. Laroux FS, Grisham MB. Immunological basis of inflammatory bowel disease: role of the microcirculation. Microcirculation 2001;8:283-301.
6. Hatoum OA, Binion DG. The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis 2005;11:304-13.
7. Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 2013; 38:1092-104.
8. Głowińska-Olszewska B, Moniuszko M, Hryniewicz A, et al. Relationship between circulating endothelial progenitor cells and endothelial dysfunction in children with type 1 diabetes: a novel paradigm of early atherosclerosis in high-risk young patients. Eur J Endocrinol 2013;168: 153-161.
9. Gkaliagkousi E, Gavriilaki E, Doumas M, et al. Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management. J Clin Rheumatol 2012;18:422-30.
10. Theocharidou E, Gossios TD, Griva T, et al. Is there an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data. Angiology 2013;65:543-50.
11. Principi M, Mastrolonardo M, Scicchitano P, et al. Endothelial function and cardiovascular risk in active inflammatory bowel diseases. J Crohns Colitis 2013;7:e427-33.
12. Aloi M, Tromba L, Di Nardo G, et al. Premature subclinical atherosclerosis in pediatric inflammatory bowel disease. J Pediatr 2012;161: 589-94.
13. Novo S, Peritore A, Trovato RL, et al. Preclinical atherosclerosis and metabolic syndrome increase cardio-and cerebrovascular events rate: a 20-year follow up. Cardiovasc Diabetol 2013;12:155.
14. Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012;34:290-6.
15. Nair SB, Malik R, Khattar RS. Carotid intima-media thickness: ultrasound measurement, prognostic value and role in clinical practice. Postgrad Med J 2012;88:694-9.
16. McGill HC Jr, McMahan CA, Herderick EE, et al. Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol 2000;20:836-45.
17. Harrington J, Peña AS, Gent R, et al. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J Pediatr 2010;156:237-41.
18. Sartorato P, Zulian E, Benedini S, et al. Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2007;92:1015-8.
19. Jarvisalo M, Jartti L, Nanto-Salonen K, et al. Increased aortic intima-media thickness. A marker of preclinical atherosclerosis in high-risk children. Circulation 2001;104:2943-7.
20. Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastro-enterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr 2007;44:653-74.
21. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a Pediatric Crohn's Disease Activity Index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
22. Turner D, Otley AR, Mack D, et al. Development, validation and evaluation of a Pediatric Ulcerative Colitis Activity Index: a prospective multicenter study. Gastroenterology 2007;133:423-32.
23. Berni A, Giuliani A, Tartaglia F, et al. Effect of vascular risk factors on increase in carotid and femoral intima-media thickness. Identification of a risk scale. Atherosclerosis 2011;216:109-14.
24. Allan PL, Mowbray PI, Lee AJ, et al. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. Stroke 1997;28:348-53.
25. Hennerici M, Meairs S. Imaging arterial wall disease. Cerebrovasc Dis 2000;10:9-20.
26. Tromba L, Blasi S, Vestri A, et al. Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation. Phlebology 2013;30:52-60.
27. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21. (see supplementary material for this reference)
28. Odgen CL, Kuezmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-60.
29. Doyon A, Kracht D, Bayazit AK, et al. Carotid artery intima-media thickness and distensibility in children and adolescents-reference values and role of body dimensions. Hypertension 2013;62:550-6.
30. McGill HC Jr, McMahan CA, Zieske AW, et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 2000;20:1998-2004.
31. Iwashima S, Ishikawa T, Akira O, et al. Association of abdominal aortic wall thickness in the newborn with maternal factors. Am J Perinatol 2012;29:441-8.
32. Skilton MR, Evans N, Griffiths KA, et al. Aortic wall thickness in newborns with intrauterine growth restriction. Lancet 2005;365:1484-6.
33. Gunes T, Koklu E, Yikilmaz A, et al. Influence of maternal smoking on neonatal aortic intima-media thickness, serum IGF-I and IGFBP-3 levels. Eur J Pediatr 2007;166:1039-44.
34. Shimizu T, Fujii T, Iwasaki J, et al. Abdominal aortic intima-media thickness in preschool children born preterm. Pediatr Cardiol 2014;35:121-5.
35. Takiuchi S, Rakugi H, Honda K, et al. Quantitative ultrasonic tissue characterization can identify high-risk atherosclerotic alteration in human carotid arteries. Circulation 2000;102:766-70.
36. Tracy R, Newman W, Wattigney W, et al. Histologic features of atherosclerosis and hypertension from autopsies of young individuals in a defined geographic population: the Bogalusa Heart Study. Atherosclerosis 1995;116:163-79.
37. Gall S, Huynh QL, Magnussen CG, et al. Exposure to parental smoking in childhood or adolescence is associated with increased carotid intima-media thickness in young adults: evidence from the Cardiovascular Risk in Young Finns study and the Childhood Determinants of Adult Health Study. Eur Heart J 2014;35:2484-91.
38. Rubenstein D, Jesty J, Bluestein D. Differences between mainstream and side stream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions. Circulation 2004;109:78-83.
39. Howard DJ, Ota RB, Briggs LA, et al. Environmental tobacco smoke in the workplace induces oxidative stress in employees, including increased production of 8-hydroxy-2-deoxyguanosine. Cancer Epidemiol Biomarkers Prev 1998;7:141-6.
40. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study. Am J Med 2004;116:145-50.
41. Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in low-density lipoprotein. Circulation 1998;97:2012-6.
42. Sinning C, Kieback A, Wild PS, et al. Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study. Clin Res Cardiol 2014;103:477-85.
43. Okumara K, Tsukamoto H, Tsuboi H, et al. High HDL cholesterol level after treatment with pivostatin is an important factor for regression in carotid intima-media thickness. Heart Vessels 2014 [Epub ahead of print].
44. Kher N, Marsh JD. Pathobiology of atherosclerosis: a brief review. Semin Thromb Hemost 2004;30:665-72.
45. Hansson GK, Robertson AK, Söderberg-Nauclér C. Inflammation and atherosclerosis. Annu Rev Pathol 2006;1:297-329.
46. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38.
47. Wilson PW. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. Am J Med 2008;121:15-20.
48. Bekwelem W, Lutsey PL, Loehr LR, et al. White blood cell count, C-reactive protein, and incident heart failure in the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2011;21:739-48.
49. Elias-Smale SE, Kardys I, Oudkerk M, et al. C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis 2007;195:195-202.
50. Zieske AW, Tracy RP, McMahan CA, et al. Elevated serum C-reactive protein levels and advanced atherosclerosis in youth. Arterioscler Thromb Vasc Biol 2005;25:1237-43.
51. Kallio K, Jokinen E, Saarinen M, et al. Arterial intima-media thickness, endothelial function, and apolipoproteins in adolescents frequently exposed to tobacco smoke. Circ Cardiovasc Qual Outcomes 2010;3: 196-203.
52. Eisenmann J. Waist circumference percentiles for 7-to 15-year-old Australian children. Acta Paediatr 2005;94:1182-5.